There are currently 407 clinical trials in Stanford, California looking for participants to engage in research studies. Trials are conducted at various facilities, including Stanford University, Stanford University School of Medicine, Stanford University Medical Center and Stanford Cancer Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
The Dynamics of Human Atrial Fibrillation
NCT05366361
Recruiting
Atrial fibrillation (AF) is an enormous public health problem in the United States, affecting 2-5 million Americans and causing rapid heart beats, stroke, heart failure or death. In this project, the applicant will develop a novel framework to better understand human AF that builds on agreement between several concepts for the disease. The applicant will develop strategies to identify AF patients who will best respond to each of several therapies, to guide personalized therapy.
Gender:
All
Ages:
Between 22 years and 80 years
Trial Updated:
11/20/2023
Locations: Stanford University, Stanford, California
Conditions: Atrial Fibrillation, Arrhythmias, Cardiac
Register for Updates
International Lymphatic Disease and Lymphedema Registry
NCT01336790
Recruiting
The purpose of the International Lymphatic Disease and Lymphedema Patient Registry and Biorepository is to collect health information in order to study the disease classification, natural history, and impact of Lymphatic Disease, Lymphedema and Related Disorders and its treatments and medical outcomes.
Gender:
All
Ages:
All
Trial Updated:
11/20/2023
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Lymphedema
Register for Updates
COMParison of Algorithms for Rotational Evaluation in Atrial Fibrillation
NCT02997254
Recruiting
This is a cohort study to evaluate algorithms for mapping atrial fibrillation by mapping atrial structure and mapping electrical activity to detect focal and rotational activity.
Gender:
All
Ages:
Between 21 years and 90 years
Trial Updated:
11/20/2023
Locations: Stanford University, Stanford, California
Conditions: Atrial Fibrillation, Abnormal Heart Rhythms
Register for Updates
Machine Learning in Atrial Fibrillation
NCT05371405
Recruiting
Atrial fibrillation is a serious public health issue that affects over 5 million Americans (Miyazaka, Circulation 2006) in whom it may cause skipped beats, dizziness, stroke and even death. Therapy for AF is currently suboptimal, in part because AF represents several disease states of which few have been delineated or used to successfully guide management. This study seeks to clarify this delineation of AF types using machine learning (ML).
Gender:
All
Ages:
Between 22 years and 80 years
Trial Updated:
11/20/2023
Locations: Stanford University, Stanford, California
Conditions: Atrial Fibrillation, Arrhythmias, Cardiac
Register for Updates
Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
NCT03868150
Recruiting
Patients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are not inducible to AF will be treated with standard post-operative care. Patients will be monitored post-operatively to explore the value of intraoperative inducibility of AF to predict POAF and to evaluate whether the combi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/20/2023
Locations: Stanford University, Stanford, California
Conditions: Postoperative Atrial Fibrillation
Register for Updates
Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
NCT03261050
Recruiting
Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. The investigators want to test whether the treatment actually changes those two mechanisms using brain scan data, which is more objective than completing questionnaires and even interviews. In the fi... Read More
Gender:
Female
Ages:
Between 18 years and 34 years
Trial Updated:
11/17/2023
Locations: Stanford University, Stanford, California
Conditions: Eating Disorder
Register for Updates
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
NCT04476901
Recruiting
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
11/15/2023
Locations: Stanford University, Stanford, California
Conditions: Non-ischemic Dilated Cardiomyopathy
Register for Updates
Evaluation of Objective Pain Measurement Device
NCT03975660
Recruiting
This study will attempt to objectively measure pain with an experimental device. The investigators will apply the device to measure patients "pain" due to uterine contractions during routine clinical care to correlate patients verbal pain ratings and analgesia requirements to that measured by the device. A brain oxygenation device, Edwards Foresight, will be used to concurrently to monitor brain oxygenation and hemodynamics, so the relationship between the CereVu ROPA device objective measure of... Read More
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
11/15/2023
Locations: Stanford University, Stanford, California
Conditions: Pain, Analgesia, Labor Pain
Register for Updates
Imaging Synapses With [11C] UCB-J in the Human Brain
NCT04038840
Recruiting
The purpose of this study is to utilize the radioactive positron emission tomography (PET) tracer [11C]UCB-J to test the neural synaptic pruning hypothesis of schizophrenia. This imaging method allows for the quantification of synaptic density in the living human brain and has the unprecedented ability to directly examine the synaptic pathology underlying neuropsychiatric disease. The neural synaptic pruning hypothesis posits that a key pathogenic process of schizophrenia is the over-exuberant e... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/15/2023
Locations: Stanford University, Stanford, California
Conditions: Schizophrenia
Register for Updates
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
NCT02461420
Recruiting
The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, including diffusion tensor imaging and identify genetic factors which contribute to diverse phenotypes in patients with PMS.
Gender:
All
Ages:
18 months and above
Trial Updated:
11/09/2023
Locations: Stanford University, Stanford, California
Conditions: Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability
Register for Updates
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
NCT02461446
Recruiting
The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.
Gender:
All
Ages:
18 months and above
Trial Updated:
11/09/2023
Locations: Stanford University Medical Center, Stanford, California
Conditions: PTEN, ASD, Autism, Macrocephaly, PTEN Hamartoma Tumor Syndrome
Register for Updates
Identifying Risk Factors That Predict Onset of Anorexia Nervosa and Bulimia Nervosa
NCT05133037
Recruiting
Across the United States, thousands of children and adolescents suffer from eating disorders. Among young women alone, an estimated 2 to 4 percent are dealing with anorexia nervosa. Anorexia nervosa also has the highest mortality rate of any psychiatric disorder and produces a six-fold increased risk for death. Unfortunately, study shows that current treatments are only successful with 25 percent of patients and no eating disorder prevention program has been found to reduce future onset of anore... Read More
Gender:
Female
Ages:
Between 12 years and 16 years
Trial Updated:
11/08/2023
Locations: Stanford University, Stanford, California
Conditions: Eating Disorders
Register for Updates